Skip to main content
Premium Trial:

Request an Annual Quote

Biosearch Strikes License Pact with Roche

NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has licensed a family of patents from Roche Molecular Systems covering uses of the 5' Nuclease process.

Novato, Calif.-based Biosearch plans to provide dual-labeled 5' Nuclease probes to Roche-licensed CLIA labs providing molecular diagnostic assay. The license provides Biosearch with freedom to operate, with respect to the Roche IP estate, for qPCR processes in the diagnostics research field, the firm said.

The firm will offer the licensed probes as custom analyte-specific reagents, and in vitro diagnostics and oligo components, Biosearch Director of Corporate Development Marc Beal said in a statement.

Financial terms of the agreement were not released.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.